Yang Kang, Liu Yue, Zhang Ji, Yu Qian, Xu Feng, Liu Jiyuan, Li Yuting, Zhang Xiaojie, Wang Zhiqiang, Wang Ning, Li Yuezhen, Shi Yan, Chen Wan-Jin
Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.
Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Clin Chem. 2025 Feb 3;71(2):319-331. doi: 10.1093/clinchem/hvae164.
Tandem repeats (TRs) are abundant in the human genome and associated with repeat expansion disorders. Our study aimed to develop a tandem repeat panel utilizing targeted long-read sequencing to evaluate known TRs associated with these disorders and assess its clinical utility.
We developed a targeted long-read sequencing panel for 70 TR loci, termed dynamic mutation third-generation sequencing (dmTGS), using the PacBio Sequel II platform. We tested 108 samples with suspected repeat expansion disorders and compared the results with conventional molecular methods.
For 108 samples, dmTGS achieved an average of 8000 high-fidelity reads per sample, with a mean read length of 4.7 kb and read quality of 99.9%. dmTGS outperformed repeat-primed-PCR and fluorescence amplicon length analysis-PCR in distinguishing expanded from normal alleles and accurately quantifying repeat counts. The method demonstrated high concordance with confirmatory methods (rlinear = 0.991, P < 0.01), and detected mosaicism with sensitivities of 1% for FMR1 CGG premutation and 5% for full mutations. dmTGS successfully identified interruptive motifs in genes that conventional methods had missed. For variable number TRs in the PLIN4 gene, dmTGS identified precise repeat counts and sequence motifs. Screening 57 patients with suspected genetic muscular diseases, dmTGS confirmed repeat expansions in genes such as GIPC1, NOTCH2NLC, NUTM2B-AS1/LOC642361, and DMPK. Additionally, dmTGS detected CCG interruptions in CTG repeats in 8 myotonic dystrophy type 1 patients with detailed characterization.
dmTGS accurately detects repeat sizes and interruption motifs associated with repeat expansion disorders and demonstrates superior performance compared to conventional molecular methods.
串联重复序列(TRs)在人类基因组中大量存在,并与重复序列扩增疾病相关。我们的研究旨在开发一种利用靶向长读长测序技术的串联重复序列检测板,以评估与这些疾病相关的已知TRs,并评估其临床实用性。
我们使用PacBio Sequel II平台,为70个TR位点开发了一种靶向长读长测序检测板,称为动态突变第三代测序(dmTGS)。我们对108例疑似重复序列扩增疾病的样本进行了检测,并将结果与传统分子方法进行了比较。
对于108个样本,dmTGS每个样本平均获得8000条高保真读数,平均读长为4.7 kb,读数质量为99.9%。在区分扩增等位基因与正常等位基因以及准确量化重复序列计数方面,dmTGS优于重复引物PCR和荧光扩增子长度分析PCR。该方法与验证方法显示出高度一致性(r线性 = 0.991,P < 0.01),并检测到嵌合体,FMR1 CGG前突变的灵敏度为1%,完全突变的灵敏度为5%。dmTGS成功识别出传统方法遗漏的基因中的中断基序。对于PLIN4基因中的可变数量TRs,dmTGS确定了精确的重复序列计数和序列基序。对57例疑似遗传性肌肉疾病患者进行筛查,dmTGS证实了GIPC1、NOTCH2NLC、NUTM2B-AS1/LOC642361和DMPK等基因中的重复序列扩增。此外,dmTGS在8例1型强直性肌营养不良患者中详细鉴定了CTG重复序列中的CCG中断。
dmTGS能够准确检测与重复序列扩增疾病相关的重复序列大小和中断基序,与传统分子方法相比表现出卓越的性能。